Tianjin Chase Sun Pharmaceutical300026 
$0.44-2.21%24h
-2.21%24h
Global rank6655
Market cap$1.32B
Change 7d-1.90%
YTD Performance-26.71%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Tianjin Chase Sun Pharmaceutical (300026)
As of November 2024, Tianjin Chase Sun Pharmaceutical has a market cap of $1.32B. This makes Tianjin Chase Sun Pharmaceutical the world's 6655th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Tianjin Chase Sun Pharmaceutical from 2009 to 2024
-
Value:-
Market cap history of Tianjin Chase Sun Pharmaceutical from 2009 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $1.66B | -7.78% |
| 2023 | $1.80B | -25.35% |
| 2022 | $2.41B | -27.46% |
| 2021 | $3.32B | 70.96% |
| 2020 | $1.94B | 30.48% |
| 2019 | $1.49B | 15.08% |
| 2018 | $1.29B | -28.40% |
| 2017 | $1.81B | -21.55% |
| 2016 | $2.30B | -22.80% |
| 2015 | $2.98B | 31.33% |
| 2014 | $2.27B | -3.24% |
| 2013 | $2.35B | 65.50% |
| 2012 | $1.42B | 103.16% |
| 2011 | $698.39M | -16.54% |
| 2010 | $836.76M | -1.47% |
| 2009 | $849.25M | - |
300026 Market Cap Today is $1.32B -2.21% - 18 Nov 2024
View largest stocks by market cap 
